Moderna COVID-19 vaccine

Vaccination with two doses of the Pfizer jab stays highly effective against severe COVID - including the Delta variant - for at least six months, an analysis of U.S. patients said on Oct. 4.

While previous data from clinical trials have shown jabs protect against hospitalization, the study published in the Lancet measures one vaccine's effectiveness over time in a real-world setting.

The number of COVID-19 vaccine jabs given in Turkey has topped 110 million since an immunization campaign was launched in January, official figures showed on Oct. 2. 

Nearly 54 million people have received their first shots, while more than 44.8 million have been fully vaccinated, according to the Health Ministry.

Ljubljana – A total of 970 new coronavirus infections were recorded in Slovenia on Thursday in what is an increase week-on-week, show fresh official data. Four Covid-19 patients died.

The number of patients in hospital dropped by one to 419 this morning, including 112 in intensive care, three more than yesterday, government data show.

Vaccination point at Sofia's St. Anna Hospital is one of the places where those wishing to be immunized can receive a third dose of the COVID-19 vaccine. This has been possible for several days now, and it will be open also on weekends.

More than 100 people have passed through the vaccination centre in three days.

Israel is pressing ahead with its aggressive campaign of offering coronavirus boosters to almost anyone over 12 and says its approach was further vindicated by a U.S. decision to give the shots to older patients or those at higher risk.

Chinese vaccine developer Beijing Wantai Biological Pharmacy Enterprise plans to start a large trial for its nasal spray-based COVID-19 vaccine candidate next month, a clinical trial registration record showed.

he CEO of US pharmaceutical company Moderna Stephane Bancel said that the Covid-19 pandemic may end in about one year as increased vaccine output guarantees enough global supplies. "If you look at the industry-wide expansion of production capacities over the past six months, enough doses should be available by the middle of next year so that everyone on this earth can be vaccinated.

It will be implemented at least six months after the second

The US Food and Drug Administration has supported the use of a booster dose of Pfizer's COVID-19 vaccine for people over the age of 65 and for some high-risk patients. The decision is to be voted on by the Board of the Centers for Control and Prevention. Most likely this will happen today.

The United States has authorized the use of boosters of Pfizer's COVID-19 vaccine for people aged over 65, as well as adults at high risk of severe disease and those in high-exposure jobs.

The announcement means a significant part of the population, amounting to tens of millions of Americans, are now eligible for a third shot six months after their second.

Prime Minister Florin Citu announced on Wednesday that a decision was made to start administering the third dose, starting with September 28, for all persons who have more than 6 months after the second dose, with any of the Pfizer BioNTech, Moderna and Astra Zeneca vaccines.